Bracco Completes Acquisition of E-Z-EM Inc.

Bracco Diagnostics, Inc. - the U.S.-based subsidiary of Bracco Imaging S.pA, and part of the Bracco Group, announced today that it has finalized the acquisition of E-Z-EM, Inc., a major manufacturer of contrast agents for gastrointestinal radiology. This acquisition further positions the companies as innovative global leaders in diagnostic imaging and allows for significant growth opportunities as E-Z-EM complements Bracco's comprehensive repertoire of diagnostic imaging agents. The synergies among both companies' product portfolios, complementary customer bases and technical expertise will strengthen Bracco Diagnostics' position in the evolving field of imaging informatics and patient management.

Click Here for More Information

Events
There are currently no upcoming events.
About Bracco
The Bracco Group is today a worldwide integrated Healthcare Group with annual turnover of about 900 million Euro - around 60% of which is from foreign sales and is one of the world-leading companies in the imaging agent business through Bracco Imaging SpA. Bracco is present in approximately 80 countries both directly and through joint-ventures or affiliates, and currently employs more than 2,300 people worldwide over 300 of which are dedicated to R&D, Medical and Regulatory Affairs.
Click Here for More Information

About Acist
ACIST is a world leader in contrast delivery solutions for the imaging field, dedicated to advancing the art of angiography through research and development of new products and technologies – supporting today's needs and anticipating those of tomorrow. More than four million people around the world have had cardiovascular angiographic procedures using an ACIST system.
Click Here for More Information